Toray Industries Inc

Toray Industries Inc maintains a capital structure with total liabilities of ¥1.58 trillion and total equity of ¥1.71 trillion, resulting in a debt-to-equity ratio of 0.49, which is below the median for the Commodity Chemicals industry. The company holds ¥237.3 billion in cash and equivalents, but its long-term debt of ¥842.7 billion suggests a reliance on long-term financing. Free cash flow is reported at ¥7.39 billion, indicating limited liquidity flexibility despite positive operating cash flow of ¥255 billion. Profitability metrics show a return on equity (ROE) of 4.56% and return on assets (ROA) of 2.37%, both below the industry median for Commodity Chemicals. Operating income of ¥127.5 billion and net income of ¥77.9 billion reflect a gross margin of 19.7% (¥505.9 billion gross profit on ¥2.56 trillion revenue), which is in line with the industry but suggests limited pricing power in a commoditized market. The company operates through five business segments, with the Textile and Functional Chemicals segments likely representing the largest revenue contributors. However, revenue concentration data is not disclosed, and the geographic exposure is primarily domestic, with no material international revenue breakdown provided. The Life Sciences segment is a newer growth area but remains a smaller portion of the business. Growth trajectory is modest, with no specific revenue growth rates provided in the latest financials. Analysts project a mean price target of ¥1,241.92, with a median of ¥1,200, and a mean recommendation of 2.54 (leaning toward "hold"). The absence of strong-buy ratings and the presence of seven "buy" and five "hold" recommendations suggest a cautious outlook. Risk factors include medium liquidity risk due to negative net cash (cash minus total debt) and a low dilution risk, with no near-term pressure from share issuance. The company has not disclosed any recent dilutive events, and the risk assessment indicates no material dilution potential in the near term. Recent events include no disclosed earnings call transcripts or regulatory filings in the provided data. The company’s latest financials reflect stable but unremarkable performance, with no material changes in capital structure or profitability in the most recent reporting period.